Stem Cells Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Stem Cells Market

1.1. Definition and Scope

1.1.1. Definition of Stem Cells

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Stem Cells Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Stem Cells Market By Product

1.2.3. Stem Cells Market By Application

1.2.4. Stem Cells Market By Technology

1.2.5. Stem Cells Market By Therapy

1.2.6. Stem Cells Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Stem Cells Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Stem Cells Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Stem Cells Market By Product

5.1. Introduction

5.2. Stem Cells Revenue By Product

5.2.1. Stem Cells Revenue (USD Billion) and Forecast, By Product, 2020-2032

5.2.2. Adult Stem Cells

5.2.2.1. Adult Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. Dental Stem Cells

5.2.2.2.1. Dental Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. Neuronal Stem Cells 

5.2.2.3.1. Neuronal Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.4. Adipose-derived Stem Cells

5.2.2.4.1. Adipose-derived Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.5. Mesenchymal Stem Cells

5.2.2.5.1. Mesenchymal Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.6. Dedifferentiated fat (DFAT) Cells

5.2.2.6.1. Dedifferentiated fat (DFAT) Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.7. HematopoieticStem Cells 

5.2.2.7.1. HematopoieticStem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.8. Umbilical Cord Stem Cells

5.2.2.8.1. Umbilical Cord Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.9. Other ASC’s

5.2.2.9.1. Other ASC’s Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Human Embryonic Stem Cells

5.2.3.1. Human Embryonic Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Very Small Embryonic Like Stem Cells

5.2.4.1. Very Small Embryonic Like Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Induced Pluripotent Stem Cells

5.2.5.1. Induced Pluripotent Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Stem Cells Market By Application

6.1. Introduction

6.2. Stem Cells Revenue By Application

6.2.1. Stem Cells Revenue (USD Billion) and Forecast, By Application, 2020-2032

6.2.2. Regenerative Medicine

6.2.2.1. Regenerative Medicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.2. Oncology

6.2.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.3. Hematology

6.2.2.3.1. Hematology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.4. Neurology

6.2.2.4.1. Neurology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.5. Injuries

6.2.2.5.1. Injuries Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.6. Liver Disorder

6.2.2.6.1. Liver Disorder Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.7. Incontinence

6.2.2.7.1. Incontinence Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.8. Diabetes

6.2.2.8.1. Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.9. Orthopedics

6.2.2.9.1. Orthopedics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.10. Others

6.2.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Drug Discovery and development

6.2.3.1. Drug Discovery and development Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Stem Cells Market By Technology

7.1. Introduction

7.2. Stem Cells Revenue By Technology

7.2.1. Stem Cells Revenue (USD Billion) and Forecast, By Technology, 2020-2032

7.2.2. Cryopreservation

7.2.2.1. Cryopreservation Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Cell Acquisition

7.2.3.1. Cell Acquisition Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3.2. Bone Marrow Harvest

7.2.3.2.1. Bone Marrow Harvest Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3.3. Apheresis

7.2.3.3.1. Apheresis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3.4. Umbilical Blood Cord

7.2.3.4.1. Umbilical Blood Cord Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Cell production

7.2.4.1. Cell production Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4.2. Isolation

7.2.4.2.1. Isolation Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4.3. Therapeutic Cloning

7.2.4.3.1. Therapeutic Cloning Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4.4. In-Vitro fertilization

7.2.4.4.1. In-Vitro fertilization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4.5. Cell Culture

7.2.4.5.1. Cell Culture Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Expansion and Sub-Culture

7.2.5.1. Expansion and Sub-Culture Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Stem Cells Market By Therapy

8.1. Introduction

8.2. Stem Cells Revenue By Therapy

8.2.1. Stem Cells Revenue (USD Billion) and Forecast, By Therapy, 2020-2032

8.2.2. Autologous Stem Cell Therapy

8.2.2.1. Autologous Stem Cell Therapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Allogenic Stem Cell Therapy

8.2.3.1. Allogenic Stem Cell Therapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Stem Cells Market By Country 

9.1. North America Stem Cells Market Overview

9.2. U.S.

9.2.1. U.S. Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

9.2.2. U.S. Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

9.2.3. U.S. Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.2.4. U.S. Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

9.3. Canada

9.3.1. Canada Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

9.3.2. Canada Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

9.3.3. Canada Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.3.4. Canada Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Stem Cells Market By Country

10.1. Europe Stem Cells Market Overview

10.2. U.K.

10.2.1. U.K. Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

10.2.2. U.K. Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.3. U.K. Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.2.4. U.K. Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.3. Germany

10.3.1. Germany Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

10.3.2. Germany Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.3. Germany Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.3.4. Germany Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.4. France

10.4.1. France Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

10.4.2. France Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

10.4.3. France Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.4.4. France Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.5. Spain

10.5.1. Spain Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

10.5.2. Spain Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

10.5.3. Spain Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.5.4. Spain Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

10.6.2. Rest of Europe Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

10.6.3. Rest of Europe Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.6.4. Rest of Europe Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Stem Cells Market By Country

11.1. Asia Pacific Stem Cells Market Overview

11.2. China

11.2.1. China Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.2. China Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.3. China Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.2.4. China Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.3. Japan

11.3.1. Japan Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.2. Japan Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.3. Japan Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.3.4. Japan Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.4. India

11.4.1. India Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.4.2. India Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.3. India Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.4.4. India Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.5. Australia

11.5.1. Australia Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.5.2. Australia Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.5.3. Australia Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.5.4. Australia Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.6. South Korea

11.6.1. South Korea Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.6.2. South Korea Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.6.3. South Korea Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.6.4. South Korea Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

11.7.2. Rest of Asia-Pacific Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

11.7.3. Rest of Asia-Pacific Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.7.4. Rest of Asia-Pacific Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Stem Cells Market By Country

12.1. Latin America Stem Cells Market Overview

12.2. Brazil

12.2.1. Brazil Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

12.2.2. Brazil Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.3. Brazil Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.2.4. Brazil Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.3. Mexico

12.3.1. Mexico Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

12.3.2. Mexico Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.3. Mexico Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.3.4. Mexico Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

12.4.2. Rest of Latin America Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.3. Rest of Latin America Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.4.4. Rest of Latin America Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Stem Cells Market By Country 

13.1. Middle East & Africa Stem Cells Market Overview

13.2. GCC

13.2.1. GCC Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

13.2.2. GCC Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

13.2.3. GCC Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.2.4. GCC Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.3. South Africa

13.3.1. South Africa Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

13.3.2. South Africa Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

13.3.3. South Africa Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.3.4. South Africa Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Stem Cells Revenue (USD Billion) and Forecast By Product, 2020-2032

13.4.2. Rest of Middle East & Africa Stem Cells Revenue (USD Billion) and Forecast By Application, 2020-2032

13.4.3. Rest of Middle East & Africa Stem Cells Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.4.4. Rest of Middle East & Africa Stem Cells Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Stem Cells Market

14.1. Stem Cells Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Stem Cells Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. STEMCELL Technologies, Inc.

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. STEMCELL Technologies, Inc. 2022 Stem Cells Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Advanced Cell Technology, Inc.

15.3. Cynata Therapeutics

15.4. Osiris Therapeutics, Inc.

15.5. Human Longevity, Inc.

15.6. Mesoblast Limited

15.7. BIOTIME, Inc.

15.8. Merck Group

15.9. Promethera Biosciences S.A. / N.V.

15.10. Takara Bio Group